Kronos Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kronos Bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Kronos Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $12.3M, a 40% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $12.3M -$8.19M -40% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $12.8M -$8.42M -39.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $13.9M -$10.2M -42.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $19.7M -$5.05M -20.4% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $20.5M -$4.82M -19.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $21.3M -$4.58M -17.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $24.1M -$2.25M -8.52% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $24.7M -$2.2M -8.17% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $25.3M -$2.16M -7.86% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $25.8M -$2.13M -7.61% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $26.4M +$1.53M +6.14% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $26.9M -$418K -1.53% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $27.4M -$1.92M -6.55% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $28M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $24.8M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $27.3M +$26.8M +5676% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $29.4M Sep 30, 2020 10-Q 2020-11-18
Q4 2019 $473K Dec 31, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.